Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 8,329-8,340 of 23,847
Drug study icon
CompletedNCT01086748

A Study in Schizophrenia Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Escondido
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States, Croatia, Russia
Sponsor
Eli Lilly and Company
Condition
Schizophrenia
Drug study icon
TerminatedNCT01125358

A Study in Schizophrenic Patients

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Aichi
SchizophreniaDrugFrom 20 Years to 65 Years
Countries
Japan, South Korea, Taiwan
Sponsor
Denovo Biopharma LLC
Condition
Schizophrenia
Drug study icon
TerminatedNCT00767715

A Study in the Treatment of Acute Mania

This summary needs review. Please check the official study record and contact the research team for details.

In Danderyd
BipolarityDrugFrom 18 Years to 60 Years
Countries
Sweden
Sponsor
Eli Lilly and Company
Condition
Bipolarity
Behavioral study icon
TerminatedNCT01077791

A Remediation Program of Social Cognition in Schizophrenia

This study was terminated in France. It is testing remediation Program of Social Cognition for schizophrenia.

In Le Chesnay
SchizophreniaBehavioralFrom 18 Years to 57 Years
Countries
France
Sponsor
Assistance Publique - Hôpitaux de Paris
Condition
Schizophrenia
Drug study icon
CompletedNCT00095758

Adjunctive Aripiprazole in people with Major Depressive Disorder

This study is completed in the United States. It is testing aripiprazole for depression.

Multiple locations, including Beverly Hills
DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Depression
Drug study icon
CompletedNCT00300846

Treatment of Aripiprazole for Schizophrenia

This study is completed in France, in the United Kingdom, in Switzerland, .... It is testing treatment of Aripiprazole for Schizophrenia.

Multiple locations, including Graz
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
France, United Kingdom, Switzerland, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00567203

Treatment Of Cognitive Deficits for schizophrenia

This study is completed in the United States. It is testing treatment Of Cognitive Deficits for schizophrenia.

Multiple locations, including Glendale
SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Pfizer
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.